Jonathan Arnold, MD, MSE

  • Assistant Professor of Medicine
  • Director of Research and Quality Improvement, UPMC McKeesport Internal Medicine Residency
  • eRecord Medical Director, UPMC
  • Associate Program Director, Clinical Informatics Fellowship
Academic Interests

Dr. Arnolds clinical interests lie int he care of medically complex patients, both in the inpatient and primary care setting, including coordination of care, facilitation of patient autonomy in complex decision making, chronic disease management, addiction management, and end of life care and planning. His research focuses on informatics approaches within general internal medicine, including the clinician-computer interface, the impact of automated risk assessment to clinical outcomes, informatics approaches for chronic disease management, and clinical decision support at the time of medical decision making. His medical education interests lie in graduate and undergraduate general internal medicine, clinical informatics, communication skills, and patient autonomy.

    Education & Training

  • BS, Engineering, University of Michigan College of Engineering, 1998
  • MS, Engineering, University of Michigan College of Engineering, 2000
  • MD, Icahn School of Medicine at Mt. Sinai, 2014
Recent Publications

Hanmer J, Arnold J, Hall A, Ratcliff JJ, Allen JW, Frankel M, Wright DW, Barrow DL, Pradilla G, Smith KJ, ENRICH Trial Investigators. Cost-effectiveness analysis of early minimally invasive removal of intracerebral hemorrhage. Stroke. 2025; 56(7):1799-1806.

Li L, Zhou T, Lu Y, Chen J, Lei Y, Wu Q, Arnold J, Becich MJ, Bisyuk Y, Blecker S, Chrischilles E, Christakis DA, Reynolds Geary C, Jhaveri R, Lenert L, Liu M, Mirhaji P, Morizono H, Mosa ASM, et al. Kidney function following COVID-19 in children and adults. JAMA Network Open. 2025; 8(4):e254129.

Shoji S, Shah NP, Shrader P, Thomas LE, Arnold JD, Dhalwani NN, Thomas NA, Kalich B, Priest EL, Syed M, Wójcik C, Peterson ED, Navar AM. Achievement of guideline-based lipid goals among very high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes: Results in 213,380 individuals from the cvMOBIUS2 registry. American Journal of Preventive Cardiology. 2025; 21.

    Honors and Awards
  • AOA Medical Honors Society, 2014